U.S. markets close in 1 hour 40 minutes
  • S&P 500

    4,137.12
    -36.30 (-0.87%)
     
  • Dow 30

    33,817.41
    -319.90 (-0.94%)
     
  • Nasdaq

    13,823.56
    -126.66 (-0.91%)
     
  • Russell 2000

    2,229.68
    -9.95 (-0.44%)
     
  • Crude Oil

    61.17
    -0.18 (-0.29%)
     
  • Gold

    1,779.50
    -13.60 (-0.76%)
     
  • Silver

    26.05
    -0.52 (-1.98%)
     
  • EUR/USD

    1.2002
    -0.0038 (-0.31%)
     
  • 10-Yr Bond

    1.5520
    -0.0120 (-0.77%)
     
  • GBP/USD

    1.3829
    -0.0103 (-0.74%)
     
  • USD/JPY

    108.1160
    +0.0730 (+0.07%)
     
  • BTC-USD

    53,030.52
    -2,757.39 (-4.94%)
     
  • CMC Crypto 200

    1,237.62
    -5.44 (-0.44%)
     
  • FTSE 100

    6,938.24
    +42.95 (+0.62%)
     
  • Nikkei 225

    29,188.17
    +679.62 (+2.38%)
     

Tronox's (TROX) Earnings & Revenues Lag Estimates in Q1

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Tronox Holdings plc TROX recorded a loss of $34 million or 27 cents per share in first-quarter 2019, narrower than a loss of $44 million or 36 cents per share a year ago.

Barring one-time items, adjusted loss for the reported quarter was 18 cents per share. Analysts polled by Zacks were expecting earnings of 6 cents per share on an average for the quarter.

Revenues fell around 12% year over year to $390 million in the reported quarter. It also missed the Zacks Consensus Estimate of $415 million. Sales were affected by lower pigment sales volumes, unfavorable currency translation and absence of revenues from the Electrolytic business sold in 2018. These were partly offset by increased zircon selling prices.

Product Revenues

Revenues from Pigment products fell 14% year over year to $286 million. Sales volumes went down 10% due to customer destocking in Europe and Asia. Selling prices fell 2% on a local currency basis and were down 5% on a U.S. dollar basis.  

Titanium feedstock and co-products sales rose 7% year over year to $104 million.  Zircon sales increased 5% to $64 million while pig iron sales were flat at $19 million.

Feedstock and other products sales climbed around 24% to $21 million on the back of increased synthetic rutile and slag fines sales volumes.

Financials

The company ended the quarter with cash and cash equivalents of $1,068 million, essentially flat year over year. Long-term debt was $3,223 million, up around 3% year over year.

Cash provided by operating activities was $39 million in the quarter. Capital expenditures were $25 million.

Outlook

The company expects adjusted EBITDA in the band of $125 million to $135 million in the second quarter for legacy Tronox operations, reflecting a significant increase from the first quarter’s tally of $80 million driven by improved pigment market conditions, higher zircon shipments and margin benefits of the actions taken before the closing of the Cristal acquisition. Tronox also expects zircon to deliver significant profitability and margin improvement.  

Price Performance

Shares of Tronox have lost 41.3% over a year, underperforming the industry’s  32.8% decline.



 

Zacks Rank and Stocks to Consider

Tronox currently carries a Zacks Rank #3 (Hold).

Better-ranked stocks in the basic materials space include Materion Corporation MTRN, Flexible Solutions International Inc. FSI and Air Products and Chemicals, Inc. APD.

Materion has an expected earnings growth rate of 23.1% for the current year and carries a Zacks Rank #1 (Strong Buy). The company’s shares are up around 18% over the past year. You can see the complete list of today’s Zacks #1 Rank stocks here.

Flexible Solutions has an expected earnings growth rate of 171.4% for the current year and carries a Zacks Rank #2 (Buy). Its shares have rallied roughly 72% in the past year.

Air Products has an expected earnings growth rate of 10.3% for the current fiscal year and carries a Zacks Rank #2. Its shares have gained around 26% in the past year.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Air Products and Chemicals, Inc. (APD) : Free Stock Analysis Report
 
Flexible Solutions International Inc. (FSI) : Free Stock Analysis Report
 
Tronox Limited (TROX) : Free Stock Analysis Report
 
Materion Corporation (MTRN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research